LAMPERT MARK N
Reporting owner on Forms 3, 4 and 5, CIK 1233840.
LAMPERT MARK N reported on 1 issuer in 1 filing, the latest a Form 3 filed 2026-10-05.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Foghorn Therapeutics Inc. CIK 1822462 | 10% owner | 1 | 2026-10-05 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Foghorn Therapeutics Inc. Common Stock, $0.0001 par value per sha…, holding | 4,494,462 | Form 3 | ||||
| Foghorn Therapeutics Inc. Common Stock, $0.0001 par value per sha…, holding | 3,232,448 | Form 3 | ||||
| Foghorn Therapeutics Inc. Common Stock, $0.0001 par value per sha…, holding | 619,258 | Form 3 | ||||
| Foghorn Therapeutics Inc. Pre-Funded Warrants to Purchase Common …, derivative, holding | Form 3 | |||||
| Foghorn Therapeutics Inc. Pre-Funded Warrants to Purchase Common …, derivative, holding | Form 3 | |||||
| Foghorn Therapeutics Inc. Pre-Funded Warrants to Purchase Common …, derivative, holding | Form 3 | |||||
| Foghorn Therapeutics Inc. Series 1 Warrants to Purchase Common St…, derivative, holding | Form 3 | |||||
| Foghorn Therapeutics Inc. Series 1 Warrants to Purchase Common St…, derivative, holding | Form 3 | |||||
| Foghorn Therapeutics Inc. Series 1 Warrants to Purchase Common St…, derivative, holding | Form 3 | |||||
| Foghorn Therapeutics Inc. Series 2 Warrants to Purchase Common St…, derivative, holding | Form 3 | |||||
| Foghorn Therapeutics Inc. Series 2 Warrants to Purchase Common St…, derivative, holding | Form 3 | |||||
| Foghorn Therapeutics Inc. Series 2 Warrants to Purchase Common St…, derivative, holding | Form 3 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 3 0000921895-26-002730 | Foghorn Therapeutics Inc. | 2026-10-05 |